Creatine is one of the most studied ingredients in sports nutrition, and brand owners abroad ask for it because the evidence base is unusually solid by supplement standards. That reputation is deserved for one specific form, at one specific dose range, for one specific type of exercise — and it is worth being precise about which.
This guide is for brand owners planning a creatine product made in Japan. It covers what the position stand from the field’s own professional society concludes, what the EU’s authorised health claim actually says, why creatine is almost always sold as a powder rather than a capsule, and what to fix before asking for a quotation.
Health supplements are foods, not medicines, and are not a substitute for medical treatment. Nothing here is a claim that any product prevents, treats or cures a disease.
💬 Planning a creatine product made in Japan? We check the full formula against Japanese food law first. See Japan-made supplement OEM.
What the research shows
The International Society of Sports Nutrition’s position stand calls creatine monohydrate the most effective ergogenic supplement currently available for high-intensity exercise capacity and lean body mass, and a meta-analysis of 60 trials backs that up for lower-limb strength.
| Study | Design | Reported result |
|---|---|---|
| Position stand, Journal of the International Society of Sports Nutrition 2017 (PMID 28615996, PMC5469049, doi 10.1186/s12970-017-0173-z) | Review of the creatine literature by the ISSN’s expert panel, covering exercise, sport and medical use | Creatine monohydrate is “the most effective ergogenic nutritional supplement currently available to athletes” for increasing high-intensity exercise capacity and lean body mass during training, with typical gains of 10–20%; short- and long-term use (up to 30 g/day for up to 5 years) is reported as safe and well tolerated in healthy people and in several patient populations |
| Systematic review and meta-analysis, Sports Medicine 2015 (PMID 25946994, doi 10.1007/s40279-015-0337-4) | 60 randomised controlled trials, 1,297 participants, creatine vs placebo for exercises under 3 minutes | Creatine supplementation improved lower-limb strength (squat and leg press), with the effect present regardless of population, training protocol, dose or duration studied |
Caveats worth keeping in view:
- Form. The position stand states directly that other forms of creatine on the market — including creatine citrate, creatine ethyl ester, buffered creatine and creatine nitrate — have not been shown to promote greater creatine retention than creatine monohydrate. The evidence base described above belongs to monohydrate specifically.
- What is not established here. Both sources above are about exercise performance and lean body mass, not cognition or ageing. Evidence for creatine and brain function is a separate, much more preliminary area of research and is not covered by this guide; do not carry performance evidence over into cognitive or healthy-ageing claims.
- Individual response. The position stand does not present response rates or a breakdown by individual, and describes its conclusions as general findings across the populations studied — it is reasonable to expect some variation between individuals, as with most training interventions, even though the cited summary does not quantify it.
- Population. Trial participants across this literature include healthy adults, athletes and some clinical populations; the ISSN position stand also reviews medical uses, which is a different context from a retail sports-nutrition product.
Checked against the published abstracts on 25 September 2026.
What Japanese products say
Creatine monohydrate is widely sold in Japan as an ordinary sports-nutrition ingredient; its Japanese labels are shaped by general food rules rather than a well-known function-claim wording.
That is different from ingredients such as GABA or lactic acid bacteria, which do have notified functions under Japan’s Foods with Function Claims system. For creatine, the practical starting point in Japan is that it is formulated and sold as a standard sports and fitness ingredient rather than marketed against a CAA-notified function. Confirm current notification status directly with the Consumer Affairs Agency’s database before finalising any Japan-market wording, since notifications change over time.
💬 Need an evidence summary for your regulatory adviser that matches your exact market and dose? We prepare it with the manufacturing documents. Tell us your market.
Wording that stays on safe ground
Describe creatine by the exercise type and dose it was studied at, not by outcomes it was not tested for.
| Safer wording | Wording to avoid |
|---|---|
| ”Studied for performance in short-duration, high-intensity exercise" | "Boosts brain power” or other cognitive claims not tested for this product |
| ”Contains 3 g creatine monohydrate per serving” | Naming a non-monohydrate form as “more effective” without its own trial evidence |
| Citing the ISSN position stand or a named trial, with its scope | ”Clinically proven” without naming the study and what it actually tested |
If you plan to use the EU’s authorised claim wording — “creatine increases physical performance in successive bursts of short-term, high intensity exercise”, conditional on a 3 g daily intake, authorised under Regulation (EU) No 432/2012 — have your own regulatory counsel confirm the exact current wording and conditions of use for your market before printing it. Treat it as a starting point, not as final legal text for your market.
How creatine is formulated
Creatine monohydrate is dosed in grams, not milligrams, which is why powder and stick-sachet formats dominate the market instead of capsules.
| Dosage form | Why brands choose it | What to weigh up |
|---|---|---|
| Powder in a tub | Lets the customer measure a loading dose or a maintenance dose | Needs a scoop and clear dosing instructions |
| Powder stick sachet | Pre-measured, travel-friendly, common in sports nutrition | Packaging cost per serving |
| Hard capsule | Familiar format for combined formulas | A 3–5 g dose needs 6–10+ capsules a day, which most brands avoid for creatine alone |
| Drink or ready-to-mix | Convenience positioning | Creatine’s stability in liquid over shelf life needs testing |
Decisions that shape the specification:
- Form. Creatine monohydrate is the form with the evidence base described above. If you are considering another form, ask the supplier for its own supporting studies rather than assuming it performs the same as monohydrate.
- Daily amount. Match the amount to the evidence you intend to cite — 3 g/day supports the EU-style claim wording; the ISSN position stand also describes a loading approach (around 20 g/day split into four doses for 5–7 days) followed by a 3–5 g/day maintenance dose, or a slower 3 g/day approach without loading.
- Companion ingredients. Creatine is frequently combined with other sport-nutrition ingredients such as electrolytes or carbohydrate. Each companion ingredient needs its own check against Japanese food law.
- Packaging and stability. Powder needs moisture-proof packaging; a ready-to-mix drink needs its own stability testing over the claimed shelf life.
The check that comes first
Every ingredient must be permitted in foods in Japan, or a Japanese factory cannot make the product.
Creatine monohydrate itself is a widely used sports-nutrition ingredient in Japan. As with any formula, the risk usually sits in companion ingredients rather than the headline ingredient — some botanicals and stimulant-type additives used in sport formulas elsewhere are treated as medicines in Japan. See the Japan-made supplement OEM page, and our GABA and hyaluronic acid guides for other examples of reading the evidence honestly before you commit to a formula.
Before you ask for a quotation
A factory can quote accurately once the form, the daily amount, the companions and the packaging are fixed.
- Creatine form (monohydrate, and its supplier specification)
- Daily amount, and whether the protocol includes a loading phase
- Dosage form (powder, stick sachet, capsule, drink)
- Companion ingredients and their amounts
- Packaging and target shelf life
- Countries you will sell in, and first order and annual volume
💬 Ready to design a Japan-made creatine product? Send us the concept — form, daily amount, dosage format and the countries you will sell in.
Frequently asked questions
1. Is creatine’s evidence base actually strong?
For creatine monohydrate and short-duration, high-intensity exercise, yes by supplement standards. The ISSN’s 2017 position stand calls it the most effective ergogenic supplement currently available for that purpose, and a 2015 meta-analysis of 60 trials supports a benefit for lower-limb strength.
2. Does that evidence apply to all forms of creatine?
No. The ISSN position stand states that other forms — citrate, ethyl ester, buffered creatine, nitrate and similar — have not been shown to give greater creatine retention than monohydrate. The strongest evidence is for monohydrate specifically.
3. Why is creatine sold as a powder instead of capsules?
Because the effective dose is measured in grams (typically 3–5 g/day for maintenance), not milligrams. Fitting that into capsules would mean many capsules a day, so powder or a stick sachet is the practical format.
4. Can I say creatine improves brain function?
Not based on the evidence in this guide. The sources here cover exercise performance and lean body mass. Cognitive and healthy-ageing claims are a separate, more preliminary area of research and are outside what this evidence supports.
5. What claim can I use in the EU?
The EU has an authorised claim for creatine and physical performance in successive bursts of high-intensity exercise, conditional on a 3 g daily intake. Confirm the exact current wording and conditions with your own regulatory counsel before using it, since we verified it through secondary compliance sources rather than the EU Register itself.
Sources: “International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine”, Journal of the International Society of Sports Nutrition 2017 (PMID 28615996, PMC5469049, doi 10.1186/s12970-017-0173-z); “Creatine Supplementation and Lower Limb Strength Performance: A Systematic Review and Meta-Analyses”, Sports Medicine 2015 (PMID 25946994, doi 10.1007/s40279-015-0337-4); EU Register of nutrition and health claims, authorised creatine claim under Regulation (EU) No 432/2012, verified via secondary regulatory-compliance sources, not the EU Register directly. Checked on 25 September 2026.